Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3 Evaxion will host a conference call and webcast to discuss the agreement on ...

Evaxion Biotech (EVAX) stock jumps 17% on expanded vaccine collaboration with MSD (MRK).

S outh Korean biotech company GI Innovation has entered a clinical trial collaboration and supply agreement with Merck & Co (MSD) to assess GI-102 in combination with Keytruda (pembrolizumab) for ...

Under the terms of the agreement, Epitopea will deploy its proprietary CryptoMap™ platform to identify and provide novel, immunogenic Cryptigen™ TSAs for a prespecified tumor type. MSD will ...

MSD will have exclusive rights to the peptide candidates for conjugation to cytotoxic payloads and will be responsible for all development aspects of any PDC products arising from the collaboration.

MANILA, Philippines — MSD recently announced the launch of its Global Health Innovation Fund (GHIF) IDEA Studios, a new initiative established to fund and collaborate with entrepreneurs and ...

Mohd Tawfik said MSD Innovation has successfully developed other IoT applications besides for smart farming purposes, comprising environment-related technologies -- early flood detection and air ...

Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on ...